Ester Caffarel-Salvador
Director, Strategic Innovation - Rare Diseases Chiesi Global Rare Diseases
Ester is the Director of Strategic Innovation at Chiesi Global Rare Diseases, where she focuses on scouting partnerships that support Chiesi’s mission to deliver transformative treatments for people living with rare and ultra-rare diseases. She is an award-winning scientist with a diverse background spanning biotechnology, bioengineering, startups, pharma, and consulting.
Seminars
Tuesday 7th April 2026
Panel Discussion: Reformulating LNPs to Achieve Extrahepatic Delivery & Expand Therapeutic Reach
2:30 pm
- Which extrahepatic targets remain the greatest unmet clinical need?
- What are the inherent biological challenges that are limiting LNPs from moving beyond the liver?
- How to better leverage formulation and administration routes to enable effective extrahepatic targeting?
Tuesday 7th April 2026
Panel Discussion: Navigating Strategic Investments by Harnessing Insights from Recent Acquisitions & Collaborations within the LNP Field
9:30 am
- What are the driving factors behind recent deals, what are the unique aspects of LNP technology that investors are most focused on?
- What key factors do investors evaluate when assessing the potential and risks of LNP technologies?
- Beyond individual drug candidates, how do investors envision the broader potential and future impact of these LNP partnerships?
